Please assess the completion status of the following clinical trial:

Trial Title: Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of KPL-404 in Healthy Subjects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SEQUENTIAL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Key Inclusion Criteria:~* Healthy subjects~* Body mass index (BMI) in the range of 18.0 - 32.0 kg/m2~Key Exclusion Criteria:~* Poor peripheral venous access~* Clinically-significant illness within 4 weeks of dose administration~* Active or acute infection requiring systemic antibiotic treatment within 2 weeks prior to Screening

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- KPL-404 (IV Administration) (Type: EXPERIMENTAL): None
- KPL-404 (SC Administration) (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).